SCHEMBL12440347

SCHEMBL12440347

CCCc1c(C)ccc2[nH]c(C)nc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 1/20 0.49
KDM4E B2RXH2 4/20 0.39
POLB P06746 1/20 0.39
NOS2 P35228 1/20 0.39
PARP1 P09874 2/20 0.37
RAB9A P51151 1/20 0.37
TSHR P16473 2/20 0.36
HSD17B10 Q99714 1/20 0.36
HTT P42858 1/20 0.35
PDE1A P54750 1/20 0.34
PDE1B Q01064 1/20 0.34
PDE1C Q14123 1/20 0.34
CCNB2 O95067 2/20 0.33
CDK1 P06493 2/20 0.33
CCNB1 P14635 2/20 0.33
GSK3A P49840 2/20 0.33
GSK3B P49841 2/20 0.33
CDK5 Q00535 2/20 0.33
CDK5R1 Q15078 2/20 0.33
CCNB3 Q8WWL7 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27156172 0.92 ADRB2 (0.48) ADRB2KDM4EPOLBPARP1TSHR
SCHEMBL9847101 0.76 ADRB2 (0.42) ADRB2KDM4EPARP1RAB9ATSHR
SCHEMBL13594653 0.74 ADRB2 (0.52) ADRB2KDM4EPARP1HTTPDE1A
SCHEMBL353026 0.74 CBFB (0.51) ADRB2KDM4EPARP1RAB9AHTT
SCHEMBL28193478 0.73 CCNB2 (0.36) ADRB2KDM4EPOLBTSHRHSD17B10
SCHEMBL29669401 0.72 ADRB2 (0.49) ADRB2PARP1HSD17B10HTTPDE1A
SCHEMBL16653940 0.72 ADRB2 (0.49) ADRB2KDM4EPOLBNOS2PARP1
SCHEMBL21608573 0.71 LMNA (0.48) ADRB2KDM4EPOLBNOS2PARP1
SCHEMBL5989876 0.71 ADRB2 (0.42) ADRB2PARP1HSD17B10HTTPDE1A
SCHEMBL3265280 0.71 HTT (0.47) ADRB2KDM4EPARP1RAB9ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011095057-A1 BENZIMIDAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS AND USES THEREOF 山东轩竹医药科技有限公司 (CN) 2011-08-11 WO disclosed